Barinthus Biotherapeutics (BRNS)

• Market cap: $48.6M
• 1 day: 6.25%
• 5 days: -6.3%
• 1 month: -24.2%
• 3 months: -9.16%
• 6 months: 19%
• Year to date: -4.03%
• 1 year: -19.59%
• 5 years: -91.56%
• 10 years: -91.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Employees: 105